OrbiMed’s LakeShore Biopharma LSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$55.9K Sell
54,799
-85,629
-61% -$87.3K ﹤0.01% 97
2025
Q1
$344K Hold
140,428
0.01% 106
2024
Q4
$486K Buy
+140,428
New +$486K 0.01% 110
2024
Q3
Sell
-140,428
Closed -$910K 127
2024
Q2
$910K Sell
140,428
-13,015
-8% -$84.3K 0.02% 105
2024
Q1
$1.1M Sell
153,443
-170,188
-53% -$1.23M 0.02% 108
2023
Q4
$1.65M Sell
323,631
-130,511
-29% -$667K 0.03% 99
2023
Q3
$3.63M Buy
454,142
+24,295
+6% +$194K 0.08% 99
2023
Q2
$5.93M Buy
429,847
+1
+0% +$14 0.11% 94
2023
Q1
$6.88M Buy
+429,846
New +$6.88M 0.14% 91